The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
7 pts

Opinion on  Amylin Pharmaceuticals Inc (AMLN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Amylin Pharmaceuticals Inc.

Jun 22, 2008 09:11 AM GMT
Foto
Return Risk
-24.55% HIGH
Principal

Fundamental Analysis  

Amylin and Mallinckrodt amended their manufacturing agreement dated October 1, 2003, pursuant to which Mallinckrodt manufactures and supplies to Amylin bulk exenatide, the active ingredient in BYETTA injection. Under the terms of the Amendment, the termination date of agreement has been extended for a period of four years to September 30, 2012.


AMLN:  This call was made on 06/22/08 @ $26.06
Rating:   Positive   $26.06 (06/22/08)
Gain/Loss:   -52.80% in 505 days
Target:   $62.00 (+137.91%) in > one year
Allocation:   0.0% of portfolio


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

Who voted on this idea?
Sad
Kenny Shen 63% 08/06/2008



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.56% 369
2 Gerald Greene 18.14 +69.43% 206
3 stockmarketfunding.com 17.66 +25.71% 53
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.75% 34


POPULAR STOCKS
Symbol Company Name Sentiment
WMT WalMart Stores Inc
JNJ Johnson & Johnson
AMD Advanced Micro Devices Inc
KO The CocaCola Company
RIO Companhia Vale Do Rio Doce
DELL Dell Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Amylin Pharmaceuticals Inc (AMLN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
41.0%
Top:
33.0%




Latest Picks by Marian Filo
Symbol SP Sentiment Rating Return Since
SVVS N/A Positive -0.72% 11/08/09
ACLI N/A Positive +3.41% 11/08/09
Y Positive +1.82% 11/06/09
PMI Positive +2.69% 11/06/09
FICO N/A Positive -5.43% 11/04/09

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch